An ongoing dialogue on HIV/AIDS, infectious diseases,
September 24th, 2011
Warning: Viral Replication is Hazardous to Your Health
When studies evaluate the prognostic importance of measuring HIV viral load, they generally do so by assessing a single measurement rather than values obtained longitudinally. One obvious limitation of this approach is that baseline VL poorly predicts outcome after ART initiation — a finding in stark contrast to the original description of VL from the MACS cohort prior to effective HIV therapy.
Now, a collaborative group of researchers report the effect of something they call “viremia copy-years,” a marker of cumulative exposure to viral replication. This “area under the viral load” curve was calculated in 2027 patients starting ART at eight US sites from 2000-2008. Total number of VL measurements was a whopping 21,665.
The results are striking: viremia copy-years strongly predicted all-cause mortality — and did so more powerfully than either cross-sectional VL measurements or CD4-cell count. Each 1-unit increase in log10 copy years/mL was independently associated with a 44% increase in mortality risk.
The take-home message from this skillfully done study is that viral replication is bad for your health — even if your CD4-cell count is OK. And why might this be the case? The authors write:
We speculate the number of viremia copy-years, as a measure of cumulative plasma HIV burden, serves as a surrogate for and perhaps is the underlying driver of cumulative inflammation and immune system activation that approximates such long-term inflammatory biomarker effects.
A few other thoughts:
- Is high viremia copy-years a lab proxy for poor medication adherence? Probably — but this doesn’t invalidate the results.
- Of course in clinical practice, few of us have the calculus skills (remember integrals?) actually to calculate something like an area under the viral load curve. OK, I don’t have the math skills.
- A study evaluating whether pre-ART viremia copy-years influences prognosis would be particularly fascinating — and highly relevant for the when-to-start question.
- The results reinforce the findings from this interesting study linking time of uncontrolled viral replication to an increased risk of lymphoma — paper summarized in Journal Watch AIDS Clinical Care.
So even though we are unlikely to start using this viremia copy-years value in clinical practice, these data certainly make intuitive sense — and reinforce the notion that getting this lethal virus under control is the logical way to improve outcomes.
Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
FROM NEJM — Recent Infectious Disease Articles- Borrelia burgdorferi Infection and Erythema Migrans January 15, 2026Expansion of the range of the lone star tick, a vector for southern tick-associated rash illness, has led to overlap with the range of the Lyme disease vector Ixodes scapularis, which may cause diagnostic uncertainty.
- Case 2-2026: A 63-Year-Old Man with Pulmonary Nodules, Liver Mass, and Vision Loss January 15, 2026A 63-year-old man was admitted to the hospital because of fever, cough, and vision loss in the right eye. He had pulmonary nodules, a liver mass, and multiple brain lesions. A diagnosis was made.
- Primary Palmoplantar Pustulosis January 15, 2026A 60-year-old man with a 30-pack-year smoking history presented with a 2-year history of a painful rash on his palms and soles. Numerous pustules with erosions, crusting, and surrounding erythema were noted.
- The Things We Carry January 15, 2026The ID, the pen, the epinephrine, the scalpel are the nonnegotiables, the necessities for any hospital shift. But they are not the only things a physician carries, and certainly not the most burdensome.
- Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance January 8, 2026Serogroup switching away from serogroup Y has been identified in the major ciprofloxacin-resistant Neisseria meningitidis strain, which may impede identification of ciprofloxacin-resistant cases of N. meningitidis infection.
- Borrelia burgdorferi Infection and Erythema Migrans January 15, 2026